Raburn Mallory, MD

Raburn Mallory, MD

Senior Vice President,
Clinical Development

Dr. Mallory is senior vice president, head of clinical development, with leadership responsibility for the clinical development organization and strategic direction of vaccine life-cycle management. He plays a key role in Novavax’ regulatory filings, including the synthesis of clinical data across Novavax’ COVID-19 clinical studies and engagement with global regulatory agencies. Prior to joining the company in 2020, he was Vice President of Clinical Development and the Global Clinical Lead for the COVID-19 and influenza vaccines at AstraZeneca. Earlier, he was a Robert Wood Johnson Clinical Scholar at Johns Hopkins University. Dr. Mallory earned his medical degree from Yale University School Medicine and undergraduate degree from Brown University.